We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: risk stratification
MedXY News
EnglishTag

risk stratification

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Time-Varying Risks in Colorectal Adenoma Recurrence: Why Histology and Demographics Demand a Personalized Surveillance Calendar
GastroenterologyColorectal Adenomaprecision oncology

Time-Varying Risks in Colorectal Adenoma Recurrence: Why Histology and Demographics Demand a Personalized Surveillance Calendar

By MedXY|Feb 5, 2026

A massive cohort study reveals that colorectal adenoma recurrence risk is not static; high-grade dysplasia, villous histology, obesity, and sex-based factors exhibit distinct time-varying patterns, necessitating a shift toward personalized,

Beyond the Binary: A New 4-Stage Stratification System Revolutionizes Cochlear Implant Candidacy Assessment
newsaudiometryCochlear Implants

Beyond the Binary: A New 4-Stage Stratification System Revolutionizes Cochlear Implant Candidacy Assessment

By MedXY|Jan 27, 2026

Researchers have developed a 4-level classification system using routine audiometric data to estimate cochlear implant candidacy likelihood. This tool moves beyond traditional binary screening, providing a probability gradient that enhances

Precision Medicine in Atrial Fibrillation: Biomarker-Based ABC-AF Risk Scores Fail to Outperform Standard Care
Cardiologyatrial fibrillationbiomarkers

Precision Medicine in Atrial Fibrillation: Biomarker-Based ABC-AF Risk Scores Fail to Outperform Standard Care

By MedXY|Jan 18, 2026

A large-scale registry-based RCT reveals that tailoring atrial fibrillation treatment using the biomarker-driven ABC-AF risk score does not significantly reduce stroke or death compared to current standard guideline-based care, highlighting

Normal T1 Mapping Values Rule Out Adverse Cardiovascular Events in Fabry Cardiomyopathy: A New Multimodal Prognostic Score
CardiologyCardiac Magnetic Resonancerisk stratification

Normal T1 Mapping Values Rule Out Adverse Cardiovascular Events in Fabry Cardiomyopathy: A New Multimodal Prognostic Score

By MedXY|Jan 5, 2026

A prospective study of 167 Fabry disease patients identifies low T1 values, left ventricular hypertrophy, and late gadolinium enhancement as key predictors of major adverse cardiac events, leading to a robust new 3-year clinical prognostic

A Universal Threshold? High-Sensitivity Troponin I Emerges as a Robust Prognostic Tool in Wild-Type Transthyretin Amyloid Cardiomyopathy
Cardiologyheart failurerisk stratification

A Universal Threshold? High-Sensitivity Troponin I Emerges as a Robust Prognostic Tool in Wild-Type Transthyretin Amyloid Cardiomyopathy

By MedXY|Dec 27, 2025

A multicenter study identifies 80 ng/L as a critical hs-cTnI threshold for mortality risk in wild-type transthyretin amyloid cardiomyopathy, offering a standardized approach for staging and prognosis across various diagnostic assays.

Elevated Natriuretic Peptides: A Potent Predictor of Heart Failure and Mortality in Asymptomatic Diabetes
CardiologyDiabetes Mellitusheart failure

Elevated Natriuretic Peptides: A Potent Predictor of Heart Failure and Mortality in Asymptomatic Diabetes

By MedXY|Dec 26, 2025

A large-scale cohort study demonstrates that screening natriuretic peptide levels in individuals with type 1 or type 2 diabetes significantly predicts incident heart failure and death, advocating for routine biomarker-based risk stratificat

Rethinking Biomarker Thresholds: Why Current NT-proBNP Cutoffs Fail Patients with Obesity and HFpEF
CardiologyHFpEFNT-proBNP

Rethinking Biomarker Thresholds: Why Current NT-proBNP Cutoffs Fail Patients with Obesity and HFpEF

By MedXY|Dec 26, 2025

A pooled analysis of 14,750 patients reveals that current fixed NT-proBNP thresholds significantly underestimate cardiovascular risk in obese patients with heart failure, suggesting a critical need for BMI-adjusted diagnostic and trial elig

Beyond Traditional Risk Scores: How Preclinical Measures Refine Heart Failure Prediction in the ARIC Study
Cardiologycardiac biomarkersheart failure

Beyond Traditional Risk Scores: How Preclinical Measures Refine Heart Failure Prediction in the ARIC Study

By MedXY|Dec 24, 2025

Recent findings from the ARIC study reveal that integrating cardiac biomarkers and echocardiography with the PREVENT-HF score significantly enhances the prediction of incident heart failure, identifying high-risk individuals who traditional

A Unified High-Sensitivity Cardiac Troponin I Threshold of 80 ng/L for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy
Cardiologyheart failurerisk stratification

A Unified High-Sensitivity Cardiac Troponin I Threshold of 80 ng/L for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy

By MedXY|Dec 24, 2025

This multicenter study identifies high-sensitivity cardiac troponin I (hs-cTnI) as a potent, independent predictor of mortality in wild-type transthyretin amyloid cardiomyopathy. A universal threshold of 80 ng/L, integrated with natriuretic

Development and Validation of an Interpretable Hybrid Machine Learning Model for Predicting Long-term Lung Transplant Outcomes
Clinical Updatesmachine learningrisk stratification

Development and Validation of an Interpretable Hybrid Machine Learning Model for Predicting Long-term Lung Transplant Outcomes

By MedXY|Dec 13, 2025

This review synthesizes evidence on a novel hybrid machine learning model leveraging US lung transplant registry data to predict mortality or retransplant risk at 1, 5, and 10 years, highlighting its clinical utility and balanced interpreta

Frailty after Acute Myocardial Infarction: A Stronger Predictor of 1‑Year Death in Younger Patients Than in the Elderly
Cardiologyacute myocardial infarctionFrailty

Frailty after Acute Myocardial Infarction: A Stronger Predictor of 1‑Year Death in Younger Patients Than in the Elderly

By MedXY|Dec 2, 2025

A large population study shows frailty is independently linked to worse 1‑year outcomes after AMI across ages, with the largest relative impact in patients under 55 — underscoring the need to assess frailty beyond geriatric populations.

PLCOm2012 Risk-Based Selection Outperforms NELSON Criteria for Lung Cancer Detection in Germany: Findings from the HANSE Cohort
newslung cancer screeningNELSON

PLCOm2012 Risk-Based Selection Outperforms NELSON Criteria for Lung Cancer Detection in Germany: Findings from the HANSE Cohort

By MedXY|Nov 25, 2025

In HANSE, PLCOm2012 (6‑year risk ≥1.58%) selected more lung cancers and yielded a lower number needed to screen than NELSON criteria, supporting risk-model selection for CT screening programs, with caveats on generalisability and mortality

Validated IMPACT Tool Enables Risk‑Stratified Outpatient Management of Incidental Meningioma
Neurologyoutpatient managementrisk stratification

Validated IMPACT Tool Enables Risk‑Stratified Outpatient Management of Incidental Meningioma

By MedXY|Nov 23, 2025

A large international cohort externally validated the IMPACT clinical tool, demonstrating accurate prediction of incidental meningioma progression and supporting triage to early intervention, serial monitoring, or safe discharge.

Septal Curvature Ratio on CTPA Identifies Normotensive PE Patients at High Risk of Early Deterioration
Critical Carepulmonary embolismrisk stratification

Septal Curvature Ratio on CTPA Identifies Normotensive PE Patients at High Risk of Early Deterioration

By MedXY|Nov 6, 2025

A multicentre prospective study shows the ventricular septum curvature ratio on CTPA strongly predicts 30‑day clinical deterioration in normotensive acute pulmonary embolism, outperforming conventional single metrics and offering potential

Rethinking Gleason Grade Group 1 Prostate Cancer: Insights from a Large-Scale Cohort Study
newsOutcomesprostate cancer

Rethinking Gleason Grade Group 1 Prostate Cancer: Insights from a Large-Scale Cohort Study

By MedXY|Oct 27, 2025

This study highlights the heterogeneity of GG1 prostate cancer and its implications for classification and management strategies.

T-Cell Receptor Clonotypes as Prognostic Markers in Cutaneous T-Cell Lymphoma: Insights from Next-Generation Sequencing
DermatologyCutaneous T-Cell Lymphomarisk stratification

T-Cell Receptor Clonotypes as Prognostic Markers in Cutaneous T-Cell Lymphoma: Insights from Next-Generation Sequencing

By MedXY|Oct 24, 2025

This study identifies specific T-cell receptor clonotypes associated with aggressive subtypes and poorer survival in mycosis fungoides and Sézary syndrome, supporting TCR sequencing as a tool for refined risk stratification in cutaneous T-c

Refining Sentinel Lymph Node Biopsy Decisions in Melanoma: Insights from the MERLIN_001 Gene Expression Profiling Study
Dermatologymelanomarisk stratification

Refining Sentinel Lymph Node Biopsy Decisions in Melanoma: Insights from the MERLIN_001 Gene Expression Profiling Study

By MedXY|Oct 24, 2025

The MERLIN_001 study validates a combined clinicopathological and gene expression profile test that accurately predicts sentinel lymph node metastasis risk in patients with cutaneous melanoma, potentially guiding safer, more personalized su

Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study
Cardiologymortality predictionrisk stratification

Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study

By MedXY|Oct 19, 2025

The updated GRACE 3.0 scoring system improves mortality prediction and personalizes early invasive treatment decisions in non-ST-elevation acute coronary syndrome across ten countries, demonstrating excellent validation and clinical utility

Harnessing Artificial Intelligence for Enhanced Prediction of Complete Heart Block Risk via Electrocardiography
AIartificial intelligenceElectrocardiography

Harnessing Artificial Intelligence for Enhanced Prediction of Complete Heart Block Risk via Electrocardiography

By MedXY|Oct 9, 2025

AIRE-CHB, a novel AI-enhanced ECG model, significantly improves prediction of incident complete heart block, outperforming traditional bifascicular block assessment and offering promising clinical utility in risk stratification and manageme

Enhancing Early Risk Stratification of Severe Childhood Febrile Illness in Rural Asia Using sTREM1 Biomarker
Emergency Medicinerisk stratification

Enhancing Early Risk Stratification of Severe Childhood Febrile Illness in Rural Asia Using sTREM1 Biomarker

By MedXY|Oct 5, 2025

A multicountry study across Asia demonstrates soluble TREM1’s superior accuracy over traditional clinical signs in predicting severe febrile illness in children, potentially transforming triage in resource-limited settings.

Prev
3 / 4
1234
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities